Advanced searches left 3/3

Chronic Kidney Disease - PubAg

Summarized by Plex Scholar
Last Updated: 15 October 2021

* If you want to update the article please login/register

Urine tungsten and chronic kidney disease in rural Colorado

The San Luis Valley is a country agricultural community in southerly Colorado with geographic and sociodemographic risk elements for CKD, consisting of a water supply contaminated by heavy metals. We obtained pre-existing sociodemographic, scientific, and urine trace metal data for 1659 topics from the San Luis Valley Diabetes Study, a possible mate study. We assessed potential associations in between pee tungsten and time-to-CKD using sped up failing time models. Depending on just how CKD was defined, a doubling of pee W was related to a 27% to 31% greater odds of developing CKD within 5 years. The relationship between urine W and pick kidney injury pens was not considerable, although pee NGAL was modified by diabetes mellitus condition. Elevated urinary system W was dramatically related to CKDu while readjusting for known CKD threat factors. Our information suggest that raised exposure to W is connected with reduced time-to-CKD and might be connected with CKDu.

Source link: https://pubag.nal.usda.gov/catalog/7241171


The Importance of Phosphate Control in Chronic Kidney Disease

A series of issues including osteopathy, irregular lotion data, and vascular calcification connected with chronic kidney disease are now jointly called CKD-mineral bone disease. The pathophysiology of CKD-MBD is becoming clear with the emerging of αKlotho, originally determined as a progeria-causing healthy protein, and bone-derived phosphaturic fibroblast development element 23 as associated aspects. Incidentally, as the pivotal roles of FGF23 and αKlotho in phosphate metabolic rate have been introduced, exactly how phosphate metabolic process and hyperphosphatemia are included in CKD-MBD and exactly how they can be medically dealt with have become of wonderful passion.

Source link: https://pubag.nal.usda.gov/catalog/7388630


Dietary zinc intake and incident chronic kidney disease

Previous studies have revealed that dietary zinc intake is carefully pertaining to cardio issues and metabolic derangements. Nutritional zinc intake was evaluated by a Food Frequency Questionnaire and dietary zinc thickness was calculated as absolute zinc intake quantity per everyday energy intake. The mean everyday zinc consumption and zinc consumption thickness were 8. 6 ± 3. 4 mg and 4. 4 ± 0. 9 mg/1000 kcal, respectively. Multivariable cox threat evaluation revealed that threat for CKD development was significantly greater in the quartile with a mean zinc consumption thickness of 3. 6 ± 0. 2 mg/1000 kcal compared with the quartile with a mean zinc consumption density of 5. 6 ± 1. 0 mg/1000 kcal. This relationship continued to be substantial even after changes for amazing factors. Low nutritional zinc intake might enhance the risk of CKD development in individuals with regular renal function.

Source link: https://pubag.nal.usda.gov/catalog/7026043


Eat Your Broccoli: Oxidative Stress, NRF2, and Sulforaphane in Chronic Kidney Disease

The pillar of therapy for chronic kidney disease is control of blood pressure and proteinuria through using angiotensin-converting enzyme inhibitors or angiotensin receptor blockers that were presented greater than 20 years ago. Many chronic kidney disease patients still proceed to end-stage kidney disease-- the supreme in failed avoidance. While increased oxidative anxiety is a major molecular support of CKD progression, no treatment modality especially targeting oxidative tension has been developed clinically.

Source link: https://pubag.nal.usda.gov/catalog/7245436


Vitamin K and D Supplementation and Bone Health in Chronic Kidney Disease—Apart or Together?

Based on the existing results of preclinical studies and professional evidence, this review means to discuss the effect of VK and VD on bone remodeling in CKD. Although the mechanisms of activity and the effects of these vitamins on bone are distinct, we attempt to find evidence for synergy in between them in regard to bone metabolic process, to address the question of whether incorporated supplementation of VK and VD will be more beneficial for bone wellness in the CKD population than administering each of these vitamins independently.

Source link: https://pubag.nal.usda.gov/catalog/7321912


Urinary magnesium predicts risk of cardiovascular disease in Chronic Kidney Disease stage 1–4 patients

Empirical studies on dietary or circulating magnesium and threat of heart disease in Chronic Kidney Disease phase 1-- 4 have reported no-to-modest inverted organizations. We examined 3179 participants aged 18-- 74 years with CKD phase 1-- 4 in the Chinese Cohort Study of Chronic Kidney Disease research, a possible population-based mate study. 24 h UMg threat versions display a small organization with CVD in CKD stage 1-- 4 patients. ClinicalTrials. gov Identifier NCT03041987.

Source link: https://pubag.nal.usda.gov/catalog/7161049


Evaluation of the progression of non-azotemic proteinuric chronic kidney disease in dogs

Proteinuria is a recognized danger element for progression of canine chronic kidney disease. Nonetheless, the diagnosis of non-azotemic proteinuric CKD in dogs has been examined just to a limited degree. The functions of this research were to identify factors associated with disease progression and to explore the degree of proteinuria, blood, and albuminuria pressure during the course of treatment connected with the progression using time-averaged pee protein: creatinine ratio and urine albumin: creatinine proportion in canine non-azotemic proteinuric CKD. In dogs with non-azotemic proteinuric CKD, much more extreme proteinuria and albuminuria were related to progression.

Source link: https://pubag.nal.usda.gov/catalog/7385240


The sweet side of dark chocolate for chronic kidney disease patients

This testimonial concentrates on the potential salutogenic contribution of delicious chocolate intake, to mitigate oxidative and inflammatory burden in CKD, its capacity, for cardiovascular security and on the maintenance of variety in intestine microbiota, along with medical viewpoints, on normal chocolate intake by CKD patients.

Source link: https://pubag.nal.usda.gov/catalog/7026048


Left ventricular hypertrophy in chronic kidney disease: A diagnostic criteria comparison

The purpose of this research study was to analyze the frequency of left ventricular hypertrophy and left ventricular geometry in a group of 293 hypertensive patients with phase 2-- 5 chronic kidney disease, compared with 289 essential hypertensive patients with typical renal function. All patients undertook echocardiographic assessment. LVH was observed in 62. 8% of patients with CKD and in 51. 9% of essential hypertensive patients. Several regression evaluation confirmed that the association between kidney function and left ventricular mass was independent by possible confounders. Diastolic function was dramatically worse in patients with CKD, specifically in advanced stages. Our study validates that LVH is extremely common in patients with CKD, specifically by utilizing the most current cut off; in this population, LVH is typically defined by the simultaneous rise of wall thicknesses and diameters with unfavorable results on diastolic function.

Source link: https://pubag.nal.usda.gov/catalog/7108367


Associations of serum bisphenol A levels with incident chronic kidney disease risk

Associations of bisphenol A degrees with renal disease are irregular. The present potential research study aims to assess the association of product BPA degrees with chronic kidney disease in a Chinese middle-aged and senior population. Multivariable logistic regression model was used to investigate relationship between lotion BPA levels and case CKD risk. At baseline, after change for numerous covariates lotion BPA degrees were negatively associated with eGFR degrees. Contrasted to those with low degrees of product BPA, participants with high degrees had a substantial adverse association with CKD [ORs = 0. 35, P < 0. 001], and this organization was not changed by conventional risk elements. Significant communication in between standard eGFR and product BPA degrees on CKD threat was found, Except subjects with 60-- 70 mL/min/1. 73 m ² eGFR at standard, inverted association robustly existed between lotion BPA degrees and incident CKD danger in the other eGFR subgroups.

Source link: https://pubag.nal.usda.gov/catalog/7270729

* Please keep in mind that all text is summarized by machine, we do not bear any responsibility, and you should always check original source before taking any actions

* Please keep in mind that all text is summarized by machine, we do not bear any responsibility, and you should always check original source before taking any actions